$AAPL
Apple Inc. Stock $aapl

$aapl Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000119312513168288 Filed on April 24, 2013

Income Statement

Concept	2013 Q1	2012 Q1
Revenue	$43.60B	$39.19B
YoY Change	11.27%	58.86%
Cost Of Revenue	$27.25B	$20.62B
YoY Change	32.16%	42.72%
Gross Profit	$16.35B	$18.56B
YoY Change	-11.93%	81.68%
Gross Profit Margin	37.5%	47.37%
Selling, General & Admin	$2.672B	$2.339B
YoY Change	14.24%	32.67%
% of Gross Profit	16.34%	12.6%
Research & Development	$1.119B	$841.0M
YoY Change	33.06%	44.75%
% of Gross Profit	6.84%	4.53%
Depreciation & Amortization	$1.692B	$740.0M
YoY Change	128.65%	70.51%
% of Gross Profit	10.35%	3.99%
Operating Expenses	$3.791B	$3.180B
YoY Change	19.21%	35.67%
Operating Profit	$12.56B	$15.38B
YoY Change	-18.37%	95.38%
Interest Expense	$0.00
YoY Change
% of Operating Profit	0.0%
Other Income/Expense, Net	$347.0M	$148.0M
YoY Change	134.46%	469.23%
Pretax Income	$12.91B	$15.53B
YoY Change	-16.91%	96.61%
Income Tax	$3.358B	$3.910B
% Of Pretax Income	26.02%	25.17%
Net Earnings	$9.547B	$11.62B
YoY Change	-17.85%	94.12%
Net Earnings / Revenue	21.9%	29.66%
Basic Earnings Per Share	$1.45	$12.45
Diluted Earnings Per Share	$1.44	$12.30
COMMON SHARES
Basic Shares Outstanding	939.6M shares	933.6M shares
Diluted Shares Outstanding	946.0M shares	944.9M shares

Balance Sheet

Concept	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$39.14B	$28.54B
YoY Change	37.14%	-2.38%
Cash & Equivalents	$12.05B	$10.12B
Short-Term Investments	$27.08B	$18.42B
Other Short-Term Assets	$6.377B	$5.050B
YoY Change	26.28%	-11.99%
Inventory	$1.245B	$1.102B
Prepaid Expenses
Receivables	$7.084B	$7.042B
Other Receivables	$6.252B	$6.727B
Total Short-Term Assets	$63.34B	$50.71B
YoY Change	24.9%	7.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.03B	$8.847B
YoY Change	69.84%	41.76%
Goodwill	$1.400B	$1.141B
YoY Change	22.7%
Intangibles	$4.136B	$3.604B
YoY Change	14.76%
Long-Term Investments	$105.6B	$81.64B
YoY Change	29.29%	123.46%
Other Assets	$5.294B	$4.992B
YoY Change	6.05%	28.49%
Total Long-Term Assets	$131.4B	$100.2B
YoY Change	31.11%	109.2%
TOTAL ASSETS
Total Short-Term Assets	$63.34B	$50.71B
Total Long-Term Assets	$131.4B	$100.2B
Total Assets	$194.7B	$150.9B
YoY Change	29.03%	59.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.91B	$17.01B
YoY Change	-12.34%	24.04%
Accrued Expenses	$13.33B	$9.778B
YoY Change	36.34%	364.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$35.51B	$32.04B
YoY Change	10.84%	31.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$20.87B	$13.95B
YoY Change	49.55%	373.02%
Total Long-Term Liabilities	$20.87B	$13.95B
YoY Change	49.55%	373.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.51B	$32.04B
Total Long-Term Liabilities	$20.87B	$13.95B
Total Liabilities	$59.25B	$48.44B
YoY Change	22.33%	44.9%
SHAREHOLDERS EQUITY
Retained Earnings	$116.6B	$87.12B
YoY Change	33.8%
Common Stock	$17.95B	$14.85B
YoY Change	20.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$135.5B	$102.5B
YoY Change
Total Liabilities & Shareholders Equity	$194.7B	$150.9B
YoY Change	29.03%	59.04%

Cashflow Statement

Concept	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	$9.547B	$11.62B
YoY Change	-17.85%	94.12%
Depreciation, Depletion And Amortization	$1.692B	$740.0M
YoY Change	128.65%	70.51%
Cash From Operating Activities	$12.50B	$13.98B
YoY Change	-10.54%	124.75%
INVESTING ACTIVITIES
Capital Expenditures	-$2.299B	-$1.509B
YoY Change	52.35%	130.03%
Acquisitions
YoY Change
Other Investing Activities	-$12.06B	-$12.97B
YoY Change	-7.01%	1397.34%
Cash From Investing Activities	-$14.36B	-$14.48B
YoY Change	-0.82%	851.12%
FINANCING ACTIVITIES
Cash Dividend Paid	$2.490B	$0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.248B	310.0M
YoY Change	-825.16%	-43.33%
NET CHANGE
Cash From Operating Activities	12.50B	13.98B
Cash From Investing Activities	-14.36B	-14.48B
Cash From Financing Activities	-2.248B	310.0M
Net Change In Cash	-4.101B	-189.0M
YoY Change	2069.84%	-103.6%
FREE CASH FLOW
Cash From Operating Activities	$12.50B	$13.98B
Capital Expenditures	-$2.299B	-$1.509B
Free Cash Flow	$14.80B	$15.49B
YoY Change	-4.41%	125.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9815000000
CY2011Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1240000000
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	938649000	shares
CY2011Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1676000000
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10121000000
CY2012Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1678000000
CY2012Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2310000000
CY2013Q1	us-gaap	Goodwill Goodwill	1400000000
CY2013Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	105550000000
CY2013Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24194000000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	30200000	shares
CY2013Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	3242000000
CY2013Q1	us-gaap	Other Assets Current OtherAssetsCurrent	6377000000
CY2013Q1	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	6252000000
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5294000000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5215000	shares
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	135490000000
CY2013Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Upper Bound SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound	850000000
CY2013Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	144003000000
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5300000000
CY2013Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5702000000
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1611000000
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-69000000
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1800000000	shares
CY2013Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	792000000
CY2013Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1000000000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	133.78
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1620000000
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	940094000	shares
CY2013Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1100000000
CY2013Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	1400000000
CY2013Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2013Q1	us-gaap	Liabilities Liabilities	59253000000
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	14912000000
CY2013Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3200000000
CY2013Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	27084000000
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7265000000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	419.79
CY2013Q1	us-gaap	Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	17001000000
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20868000000
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	116572000000
CY2013Q1	us-gaap	Assets Assets	194743000000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	133.50
CY2013Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	16481000000
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7084000000
CY2013Q1	us-gaap	Inventory Net InventoryNet	1245000000
CY2013Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	823000000
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	194743000000
CY2013Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3639000000
CY2013Q1	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	1444000000
CY2013Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	769000000
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12053000000
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	139000000
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	940094000	shares
CY2013Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3014000000
CY2013Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4136000000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	25000	shares
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	964000000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	15765000	shares
CY2013Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13331000000
CY2013Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	4387000000
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	35508000000
CY2013Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	99000000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5240000	shares
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	516000000
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	17954000000
CY2013Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Lower Bound SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeLowerBound	800000000
CY2013Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2877000000
CY2013Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1610000000
CY2013Q1	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	2600000000
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	517000000
CY2013Q1	us-gaap	Assets Current AssetsCurrent	63337000000
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4500000000
CY2013Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9168000000
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15026000000
CY2013Q1	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	144687000000
CY2013Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	539000000
CY2013Q1	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	134000000
CY2013Q1	aapl	Land And Buildings Gross LandAndBuildingsGross	2818000000
CY2013Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedTotalIntrinsicValue	6979000000
CY2013Q1	aapl	Machinery Equipment And Internal Use Software Gross MachineryEquipmentAndInternalUseSoftwareGross	17737000000
CY2013Q1	aapl	Operating Leases Future Minimum Payments Due Retail Space OperatingLeasesFutureMinimumPaymentsDueRetailSpace	3200000000
CY2013Q1	aapl	Notional Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	30925000000
CY2013Q1	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	1026000000
CY2013Q1	aapl	Prepaid Expense Other Current Noncurrent PrepaidExpenseOtherCurrentNoncurrent	3600000000
CY2013Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Intrinsic Value At Period End ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestIntrinsicValueAtPeriodEnd	9000000
CY2013Q1	aapl	Collateral Already Received Aggregate Fair Value CollateralAlreadyReceivedAggregateFairValue	940000000
CY2013Q1	aapl	Number Of Countries NumberOfCountries	13	Country
CY2013Q1	aapl	Number Of Customers With Significant Accounts Receivable Balance NumberOfCustomersWithSignificantAccountsReceivableBalance	1	Customer
CY2013Q1	aapl	Number Of Significant Vendors NumberOfSignificantVendors	3	Vendor
CY2013Q1	aapl	Long Term Marketable Securities Maturities Term Minimum LongTermMarketableSecuritiesMaturitiesTermMinimum	P1Y
CY2013Q1	aapl	Long Term Marketable Securities Maturities Term Maximum LongTermMarketableSecuritiesMaturitiesTermMaximum	P5Y
CY2013Q1	aapl	Major Facility Lease Terms Maximum Period MajorFacilityLeaseTermsMaximumPeriod	P10Y
CY2013Q1	aapl	Retail Lease Terms Majority Period RetailLeaseTermsMajorityPeriod	P10Y
CY2013Q1	aapl	Retail Lease Terms Maximum Period RetailLeaseTermsMaximumPeriod	P20Y
CY2013Q1	aapl	Retail Lease Terms Minimum Period RetailLeaseTermsMinimumPeriod	P5Y
CY2013Q1	aapl	Renewal Option Terms Maximum Additional Period RenewalOptionTermsMaximumAdditionalPeriod	P5Y
CY2013Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Assumed Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedWeightedAverageExercisePrice	210.08
CY2013Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice	73.52
CY2013Q1	aapl	Off Balance Sheet Inventory Purchase Commitment OffBalanceSheetInventoryPurchaseCommitment	13800000000
CY2013Q1	aapl	Amount Of Estimated Range Of Reasonably Possible Change In Unrecognized Tax Benefits That Would Impact Effective Tax Rate AmountOfEstimatedRangeOfReasonablyPossibleChangeInUnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	50000000
CY2012Q3	us-gaap	Goodwill Goodwill	1135000000
CY2012Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	92122000000
CY2012Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21887000000
CY2012Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2583000000
CY2012Q3	us-gaap	Other Assets Current OtherAssetsCurrent	6458000000
CY2012Q3	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	7762000000
CY2012Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5478000000
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	118210000000
CY2012Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	120220000000
CY2012Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5104000000
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	8000000
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1800000000	shares
CY2012Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	735000000
CY2012Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	939208000	shares
CY2012Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	889000000
CY2012Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2012Q3	us-gaap	Liabilities Liabilities	57854000000
CY2012Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	21175000000
CY2012Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2100000000
CY2012Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	18383000000
CY2012Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5953000000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	344.87
CY2012Q3	us-gaap	Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	13403000000
CY2012Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16664000000
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	101289000000
CY2012Q3	us-gaap	Assets Assets	176064000000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	127.56
CY2012Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	13847000000
CY2012Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10930000000
CY2012Q3	us-gaap	Inventory Net InventoryNet	791000000
CY2012Q3	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1051000000
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	176064000000
CY2012Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3464000000
CY2012Q3	us-gaap	Collateral Already Posted Aggregate Fair Value CollateralAlreadyPostedAggregateFairValue	278000000
CY2012Q3	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	1492000000
CY2012Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	910000000
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10746000000
CY2012Q3	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	20000000
CY2012Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	939208000	shares
CY2012Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1638000000
CY2012Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4224000000
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	499000000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	15005000	shares
CY2012Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11414000000
CY2012Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2817000000
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	38542000000
CY2012Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	98000000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6545000	shares
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	731000000
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	16422000000
CY2012Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2648000000
CY2012Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1535000000
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	-240000000
CY2012Q3	us-gaap	Assets Current AssetsCurrent	57653000000
CY2012Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6435000000
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15452000000
CY2012Q3	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	121251000000
CY2012Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	401000000
CY2012Q3	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	12000000
CY2012Q3	aapl	Land And Buildings Gross LandAndBuildingsGross	2439000000
CY2012Q3	aapl	Machinery Equipment And Internal Use Software Gross MachineryEquipmentAndInternalUseSoftwareGross	15984000000
CY2012Q3	aapl	Notional Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	41970000000
CY2012Q3	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	140000000
CY2012Q3	aapl	Prepaid Expense Other Current Noncurrent PrepaidExpenseOtherCurrentNoncurrent	4200000000
CY2012Q3	aapl	Number Of Customers With Significant Accounts Receivable Balance NumberOfCustomersWithSignificantAccountsReceivableBalance	2	Customer
CY2012Q3	aapl	Number Of Significant Vendors NumberOfSignificantVendors	3	Vendor
	dei	Trading Symbol TradingSymbol	AAPL
	dei	Entity Registrant Name EntityRegistrantName	APPLE INC
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-03-30
	dei	Entity Central Index Key EntityCentralIndexKey	0000320193
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-28
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3658000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	558000000
	us-gaap	Operating Income Loss OperatingIncomeLoss	29768000000
	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-51000000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4422000000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	275000000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y6M
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	299000000
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	2909000000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23090000000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	9243000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	4059000	shares
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	1052000000
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1533000000
	us-gaap	Share Based Compensation ShareBasedCompensation	1120000000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	23.90
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	113.45
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4325000000
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1328000	shares
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	60706000000
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	5.30
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	757000000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1950000000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	35930000000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27878000000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	154000000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1541000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	2790000	shares
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	603000000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	106.02
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	-188000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1700000000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1307000000
	us-gaap	Operating Expenses OperatingExpenses	7641000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	420.69
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	939273000	shares
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1269000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	261.17
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	587.83
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y2M12D
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	946626000	shares
	us-gaap	Sales Revenue Net SalesRevenueNet	98115000000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3846000000
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	2582782	shares
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-77000000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	30577000000
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	409000000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	465000000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	24.09
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2129000000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6745000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	6000	shares
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	81163000000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	588000000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	454000000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	7353000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y6M
	us-gaap	Maximum Length Of Time Hedged In Cash Flow Hedge1 MaximumLengthOfTimeHedgedInCashFlowHedge1	P6M
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4258000000
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	5.30
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	93000000
	us-gaap	Gross Profit GrossProfit	37409000000
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	49188000000
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	There was one customer that accounted for 11% of the Company’s trade receivables as of March 30, 2013.
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	429000000
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	3280000000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1957000000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4000000	shares
	us-gaap	Net Income Loss NetIncomeLoss	22625000000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	809000000
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	502000000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5512000000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1510000000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7952000000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-118000000
	us-gaap	Payments Of Dividends PaymentsOfDividends	5000000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	509000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	407.80
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-215000000
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm	P7Y8M12D
	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	3631000000
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriod	29000	shares
	aapl	Range Of Time Hedged In Cash Flow Hedge RangeOfTimeHedgedInCashFlowHedge	The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases generally up to six months.
	aapl	Schedule Of Derivative Instruments Effect On Income And Other Comprehensive Income ScheduleOfDerivativeInstrumentsEffectOnIncomeAndOtherComprehensiveIncome	<div> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="justify"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table shows the pre-tax effect of the Company’s derivative instruments designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 30, 2013 and March 31, 2012 (in millions):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"><!-- Begin Table Head --> <tr> <td width="22%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td width="14%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="24" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Three Months Ended</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses)<br /> Recognized in OCI -</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Portion</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses)</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Reclassified  from AOCI</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>into Net Income -</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Portion</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="8" align="center"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses) Recognized – Ineffective</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Portion and Amount Excluded from</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effectiveness Testing</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 30,<br /> 2013</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 30,<br /> 2013 (a)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>2012 (b)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Location</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 30,<br /> 2013</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cash flow hedges:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">741</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(32</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(29</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">146</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Other income and expense</font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(61</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(140</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net investment hedges:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">70</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Other income and expense</font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">811</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(32</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(29</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">146</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(60</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(140</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <tr> <td height="16"></td> <td height="16" colspan="26"></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="24" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Six Months Ended</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses)<br /> Recognized in OCI -</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Portion</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses)<br /> Reclassified from AOCI</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>into Net Income -<br /> Effective Portion</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="8" align="center"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses) Recognized – Ineffective</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Portion and Amount Excluded from</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effectiveness Testing</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 30,<br /> 2013</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 30,<br /> 2013 (c)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012 (d)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Location</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 30,<br /> 2013</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March 31,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cash flow hedges:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">946</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">103</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(188</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">384</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Other income and expense</font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(52</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(209</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net investment hedges:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">106</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Other income and expense</font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,052</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(188</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">384</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(51</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(208</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px">  </p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $(155) million and $126 million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended March 30, 2013.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $154 million and $(8) million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended March 31, 2012.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $(164) million and $(24) million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the six months ended March 30, 2013.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $341 million and $43 million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the six months ended March 31, 2012.</font></p> </td> </tr> </table> </div>
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	125.46
	aapl	Prepaid Expense And Other Current Noncurrent Utilized PrepaidExpenseAndOtherCurrentNoncurrentUtilized	677000000
	aapl	Stock Repurchase Program Completion Date StockRepurchaseProgramCompletionDate	April 1, 2013
	aapl	Purchase Commitment Coverage Period PurchaseCommitmentCoveragePeriod	P150D
	aapl	Payments Of Dividends And Dividend Equivalents On Common Stock And Restricted Stock Units PaymentsOfDividendsAndDividendEquivalentsOnCommonStockAndRestrictedStockUnits	4984000000
	aapl	Upfront Payment Under Accelerated Share Repurchase Program UpfrontPaymentUnderAcceleratedShareRepurchaseProgram	1950000000
	aapl	Adjustment For Gain Loss On Investments Included In Net Income Net Of Tax AdjustmentForGainLossOnInvestmentsIncludedInNetIncomeNetOfTax	97000000
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	778000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1200000000
	us-gaap	Operating Income Loss OperatingIncomeLoss	32724000000
	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-208000000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2809000000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	377000000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	350000000
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1303000000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24767000000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	7702000000
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	110000000
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	865000000
	us-gaap	Share Based Compensation ShareBasedCompensation	844000000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	26.17
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2778000000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46252000000
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.00
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-185000000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31531000000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31604000000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	-251000000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1916000000
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	66000000
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	384000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1600000000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	306000000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1510000000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	943185000	shares
	us-gaap	Sales Revenue Net SalesRevenueNet	85519000000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1663000000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3000000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	33009000000
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	301000000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	81000000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	26.48
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1599000000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	379000000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	85022000000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	634000000
	us-gaap	Operating Expenses OperatingExpenses	6543000000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	932265000	shares
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	326000000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	10920000	shares
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4835000000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	48000000
	us-gaap	Gross Profit GrossProfit	39267000000
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	49052000000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	160000000
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1461000000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2915000000
	us-gaap	Net Income Loss NetIncomeLoss	24686000000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	285000000
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	636000000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4944000000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	379000000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8323000000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	303000000
	us-gaap	Payments Of Dividends PaymentsOfDividends	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	400.79
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	263000000
	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	2653000000
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriod	41000	shares
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	96.83
	aapl	Payments Of Dividends And Dividend Equivalents On Common Stock And Restricted Stock Units PaymentsOfDividendsAndDividendEquivalentsOnCommonStockAndRestrictedStockUnits	0
	aapl	Certain Manufacturing Costs And Variances CertainManufacturingCostsAndVariances	194000000
	aapl	Adjustment For Gain Loss On Investments Included In Net Income Net Of Tax AdjustmentForGainLossOnInvestmentsIncludedInNetIncomeNetOfTax	40000000
CY2013Q2	aapl	Stock Repurchase Program New Authorized Amount StockRepurchaseProgramNewAuthorizedAmount	60000000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	719000000
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15384000000
CY2012Q1	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-140000000
CY2012Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	466000000
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11762000000
CY2012Q1	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	-32000000
CY2012Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	464000000
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	424000000
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	12.30
CY2012Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20622000000
CY2012Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.00
CY2012Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-118000000
CY2012Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	-97000000
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-21000000
CY2012Q1	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	146000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	625000000
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	944893000	shares
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	39186000000
CY2012Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9000000
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15532000000
CY2012Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	156000000
CY2012Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	140000000
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	12.45
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	841000000
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	3180000000
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	933582000	shares
CY2012Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11311000	shares
CY2013Q1	us-gaap	Gross Profit GrossProfit	16349000000
CY2012Q1	us-gaap	Gross Profit GrossProfit	18564000000
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	11622000000
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	148000000
CY2012Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2339000000
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3910000000
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	276000000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	400.79
CY2012Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	249000000
CY2012Q1	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	1378000000
CY2012Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriod	41000	shares
CY2012Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	105.25
CY2012Q1	aapl	Certain Manufacturing Costs And Variances CertainManufacturingCostsAndVariances	243000000
CY2012Q1	aapl	Adjustment For Gain Loss On Investments Included In Net Income Net Of Tax AdjustmentForGainLossOnInvestmentsIncludedInNetIncomeNetOfTax	27000000
CY2012Q4	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	10000000000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	211000000
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	12558000000
CY2013Q1	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-60000000
CY2013Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1551000000
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9899000000
CY2013Q1	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	811000000
CY2013Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	847000000
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	575000000
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	10.09
CY2013Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	27254000000
CY2013Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.65
CY2013Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	499000000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	42000000
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	457000000
CY2013Q1	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	-29000000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	151000000
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	946035000	shares
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	43603000000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-51000000
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	12905000000
CY2013Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	195000000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	352000000
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.16
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1119000000
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	3791000000
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	939629000	shares
CY2013Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6406000	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4300000	shares
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	9547000000
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	347000000
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2672000000
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3358000000
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-52000000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-96000000
CY2013Q1	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	1932000000
CY2013Q1	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	115.99
CY2013Q1	aapl	Prepaid Expense And Other Current Noncurrent Utilized PrepaidExpenseAndOtherCurrentNoncurrentUtilized	354000000
CY2013Q1	aapl	Adjustment For Gain Loss On Investments Included In Net Income Net Of Tax AdjustmentForGainLossOnInvestmentsIncludedInNetIncomeNetOfTax	44000000
CY2013Q1	aapl	Portion Of Product Warranty Accrual Associated With Prior Period Sales PortionOfProductWarrantyAccrualAssociatedWithPriorPeriodSales	414000000
CY2013Q1	aapl	Portion Of Product Warranty Accrual Associated With Prior Period Sales Reflecting Changes In Estimated Warranty Costs PortionOfProductWarrantyAccrualAssociatedWithPriorPeriodSalesReflectingChangesInEstimatedWarrantyCosts	224000000

Files In Submission

Name	View Source	Status
0001193125-13-168288-index-headers.html	Edgar Link	completed
0001193125-13-168288-index.html	Edgar Link	completed
0001193125-13-168288.txt	Edgar Link	completed
0001193125-13-168288-xbrl.zip	Edgar Link	completed
aapl-20130330.xml	Edgar Link	completed
aapl-20130330.xsd	Edgar Link	completed
aapl-20130330_cal.xml	Edgar Link	unprocessable
aapl-20130330_def.xml	Edgar Link	unprocessable
aapl-20130330_lab.xml	Edgar Link	unprocessable
aapl-20130330_pre.xml	Edgar Link	unprocessable
d501596d10q.htm	Edgar Link	completed
d501596dex311.htm	Edgar Link	completed
d501596dex312.htm	Edgar Link	completed
d501596dex321.htm	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	completed
R1.htm	Edgar Link	completed
R10.htm	Edgar Link	completed
R11.htm	Edgar Link	completed
R12.htm	Edgar Link	completed
R13.htm	Edgar Link	completed
R14.htm	Edgar Link	completed
R15.htm	Edgar Link	completed
R16.htm	Edgar Link	completed
R17.htm	Edgar Link	completed
R18.htm	Edgar Link	completed
R19.htm	Edgar Link	completed
R2.htm	Edgar Link	completed
R20.htm	Edgar Link	completed
R21.htm	Edgar Link	completed
R22.htm	Edgar Link	completed
R23.htm	Edgar Link	completed
R24.htm	Edgar Link	completed
R25.htm	Edgar Link	completed
R26.htm	Edgar Link	completed
R27.htm	Edgar Link	completed
R28.htm	Edgar Link	completed
R29.htm	Edgar Link	completed
R3.htm	Edgar Link	completed
R30.htm	Edgar Link	completed
R31.htm	Edgar Link	completed
R32.htm	Edgar Link	completed
R33.htm	Edgar Link	completed
R34.htm	Edgar Link	completed
R35.htm	Edgar Link	completed
R36.htm	Edgar Link	completed
R37.htm	Edgar Link	completed
R38.htm	Edgar Link	completed
R39.htm	Edgar Link	completed
R4.htm	Edgar Link	completed
R40.htm	Edgar Link	completed
R41.htm	Edgar Link	completed
R42.htm	Edgar Link	completed
R5.htm	Edgar Link	completed
R6.htm	Edgar Link	completed
R7.htm	Edgar Link	completed
R8.htm	Edgar Link	completed
R9.htm	Edgar Link	completed
report.css	Edgar Link	completed
Show.js	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AAPL
Apple Inc. Stock $aapl

2013 Q1 Form 10-Q Financial Statement

#000119312513168288 Filed on April 24, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAPL Apple Inc. Stock $aapl

2013 Q1 Form 10-Q Financial Statement

#000119312513168288 Filed on April 24, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAPL
Apple Inc. Stock $aapl